Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
HEI Therapeutics ApS
APS
In liquidation
Reklamebeskyttelse
CVR 42613207
Ole Maaløes Vej 3, 2200
København N
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2021 · 4 years old
1 employees
hei.care
Overvåg
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
HEI Therapeutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
1M
2M
3M
5M
4M
2022
4M
2023
2M
2024
EBITDA
DKK millions
0M
-1M
-1M
-2M
-3M
0M
2022
0M
0%
2023
-2M
-200%
2024
Income statement
DKK thousands
Item
2022
2023
2024
Gross profit
3.883
3.936
1.762
Staff expenses
-3.988
-4.041
-3.409
EBITDA
-104
-105
-1.647
Depreciation & amort.
-0
-0
-13.180
EBIT
-104
-105
-14.827
Net financials
-259
-529
-630
Profit before tax
-363
-634
-15.457
Tax
-79
-252
-2.567
Net profit
-284
-382
-12.890
Balance sheet
DKK thousands
Item
2022
2023
2024
Total assets
12.178
20.999
2.359
Equity
-244
-626
-13.517
Long-term debt
9.231
10.470
11.006
Short-term debt
1.812
8.473
4.870
Total debt
11.043
18.943
15.876
Financial ratios
5-year trend
EBITDA-margin (af bruttofortjeneste)
-93.4%
This company
2022
2024
Soliditetsgrad
-572.9%
This company
38.2%
Market median
-1600% vs market
2022
2024
Egenkapitalforrentning
-1289041400.0%
This company
18.4%
Market median
-7005659883% vs market
2022
2024
Nettoresultatgrad (af bruttofortjeneste)
-731.4%
This company
2022
2024
Aktivomsætning (af bruttofortjeneste)
0.75×
This company
2022
2024
Gæld/egenkapital
1.17×
This company
0.62×
Market median
-89% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-08-20 – 2022-12-31
View
PDF
More on HEI Therapeutics ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
